Delivery Order SPE2DR25D2104-SPE2DR26F3TEH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12.5K to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TRIUMEQ is a combination antiretroviral medication used in HIV treatment, reflecting the Defense Logistics Agency Medical Supply...
- The Defense Logistics Agency awarded a delivery order valued at $10,541.99 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on September 5, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TRIUMEQ is an antiretroviral combination therapy used for HIV treatment,...
- The Defense Logistics Agency awarded a delivery order valued at $12,886.43 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on August 4, 2025, with completion targeted for August 5, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $11,525.99 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30s. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of August 20, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on January 2, 2026, with a ceiling value of $7,589.09 and ultimate completion date of January 5, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. TRIUMEQ is an antiretroviral combination medication used in HIV treatment and management....
- The Defense Logistics Agency awarded a delivery order valued at $14,373.49 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count unit dose packaging) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office located in Conshohocken, Pennsylvania. TRIUMEQ is a combination antiretroviral medication used in HIV treatment, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) valued at $12,781.54 under a firm fixed price contract type. The award, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a competitively awarded, non-set-aside procurement. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $33,210.45 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. The contract employs firm fixed pricing and is classified as a non-set-aside competitive award, with an ultimate completion date of August 11, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order valued at $8,910.52 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets (30-count units) on September 4, 2025, with completion expected by September 5, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a $8,537.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) with an ultimate completion date of October 23, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The place of performance is AmerisourceBergen's...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3TEHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,627.08 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on January 8, 2026, with completion scheduled for January 9, 2026. This firm fixed-price, non-set-aside contract is performed at the awardee's facility in Conshohocken, Pennsylvania. The order represents a task order against AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. TRIUMEQ is an antiretroviral medication used in the treatment of HIV infection, reflecting the Defense Logistics Agency's ongoing procurement of essential pharmaceuticals for military personnel and beneficiaries across the federal healthcare system. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its comprehensive portfolio of brand-name and generic medications. This delivery order exemplifies the routine pharmaceutical supply operations conducted under DLA's broader medical supply chain, supporting the Defense Health Agency and other federal healthcare beneficiaries worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 1/7/26 |